Investor CHI Advisors LLC
13D/G Filings

This page shows a list of all the recent 13D/G filings made by CHI Advisors LLC . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2023-02-13 13G/A CGEM / Cullinan Therapeutics, Inc. 2,476,720 3,317,544
2023-02-13 13G/A ONCR / Oncorus, Inc. 2,106,903 2,367,436
2023-02-13 13G/A PLRX / Pliant Therapeutics, Inc. 2,569,479 3,199,892
2023-02-13 13G INZY / Inozyme Pharma, Inc. 2,204,876
2023-02-13 13G/A VECT / VectivBio Holding AG 2,675,408 5,492,893
2023-02-13 13G/A RPTX / Repare Therapeutics Inc. 2,212,256 2,800,126
2023-02-13 13G/A ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock) 6,449,856 7,987,396
2023-02-13 13G/A LRMR / Larimar Therapeutics, Inc. 1,515,148 3,473,366
2023-02-13 13G CRVS / Corvus Pharmaceuticals, Inc. 2,384,402
2023-02-13 13G/A US35655L1070 / Freeline Therapeutics Holdings PLC 1,876,389 4,814,419
2022-02-11 13G/A PLRX / Pliant Therapeutics, Inc. 2,354,799 2,569,479
2022-02-11 13G/A ONCR / Oncorus, Inc. 1,679,906 2,106,903
2022-02-11 13G CGEM / Cullinan Therapeutics, Inc. 2,476,720
2022-02-11 13G ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock) 6,449,856
2022-02-11 13G FRLN / Freeline Therapeutics Holdings plc - Depositary Receipt (Common Stock) 1,876,389
2022-02-11 13G VECT / VectivBio Holding AG 2,675,408
2022-02-11 13G/A RPTX / Repare Therapeutics Inc. 2,532,150 2,212,256
2022-02-11 13G/A LRMR / Larimar Therapeutics, Inc. 1,515,148 1,515,148
2021-03-02 13G PLRX / Pliant Therapeutics, Inc. 2,354,799
2021-03-02 13G ONCR / Oncorus, Inc. 1,679,906
2021-03-02 13G RPTX / Repare Therapeutics Inc. 2,532,150
2021-03-02 13G LRMR / Larimar Therapeutics, Inc. 1,515,148